Clinical Trial Update: Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ATI-450 plus methotrexate versus methotrexate alone in moderate to severe rheumatoid arthritis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ATI-450
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2023-03-29